Concepedia

Katy J. Brocklehurst

KJ

11

Publications

952

Citations

10

H-Index

1994

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

AstraZeneca (Sweden)

University of Exeter

Newcastle University

Katy J. Brocklehurst is an author at AstraZeneca (United Kingdom) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1994–2014

11

Publications

11

Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell‐permeable activator of AMP‐activated protein kinase

Jane E. Sullivan, Katy J. Brocklehurst, Anna E. Marley et al. · FEBS Letters · 1994 · 484 citations · Full text

Stimulation of Hepatocyte Glucose Metabolism by Novel Small Molecule Glucokinase Activators

Katy J. Brocklehurst, Victoria A. Payne, Rick A. Davies et al. · Diabetes · 2004 · 130 citations · Full text

GPR120 (FFAR4) is preferentially expressed in pancreatic delta cells and regulates somatostatin secretion from murine islets of Langerhans

Virginia M. Stone, Shalinee Dhayal, Katy J. Brocklehurst et al. · Diabetologia · 2014 · 129 citations · Full text

Use of Small-Molecule Crystal Structures To Address Solubility in a Novel Series of G Protein Coupled Receptor 119 Agonists: Optimization of a Lead and in Vivo Evaluation

James S. Scott, Alan M. Birch, Katy J. Brocklehurst et al. · Journal of Medicinal Chemistry · 2012 · 74 citations · Full text

, , +17

Differences in regulatory properties between human and rat glucokinase regulatory protein

Katy J. Brocklehurst, Rick A. Davies, Loranne Agius · Biochemical Journal · 2004 · 33 citations · Full text

, , +17

Rows per page

1–5 of 11